Copies of letters sent to healthcare professionals in December 2012, to inform of new safety information and advice:
Date sent | Medicine | Safety information |
---|---|---|
3 December 2012 | Sprayable Evicel fibrin sealant![]() |
Risk of life-threatening air embolism. |
10 December 2012 | Lapatinib (Tyverb)![]() |
Lapatinib combined with capecitabine has poorer efficacy compared with trastuzumab combined with capecitabine. |
10 December 2012 | Lenalidomide (Revlimid)![]() |
Risk of hepatic disorders – routine monitoring of liver function, and dose adjustments in patients with renal impairment, are recommended. |